Immunotherapy in allergic rhinitis
- PMID: 11763723
Immunotherapy in allergic rhinitis
Abstract
Allergen specific immunotherapy (IT) represents a cornerstone of allergic rhinitis treatment and his efficacy has been confirmed, through open and double blind trials and meta-analysis. In the last few years non invasive routs for IT (oromucosal, nasal) were developed gained general acceptation mainly in children and were validated by WHO. The efficacy of IT could be markers, the pattern of specific antibody response or by the effect on sequential nasal challenges. We have evaluated the effect of IT in allergic rhinitis by different methods. Nasal IT decreased mean symptoms and pharmacological scores as well as in seasonal as in perennial rhinitis. The same decrease has been observed after oromucosal IT. The effect of IT in allergic inflammation has been confirmed by a decrease in the level of soluble adhesion molecule sVCAM-1 which is related to eosinophilic inflammation but not statistically for sICAM-1. We have also evaluated the immunoblotting pattern or specific IgE after oromucosal IT for house dust mites. For D. pteronyssinus in 4 patients the bands intensity decreased and in 3 patients the bands decreased and in 10 disappeared. IT decreases tryptase and ECP in nasal lavage after sequential nasal challenges. Therefore IT decreases clinical scores, inflammation markers, specific IgE immunoblotting bands and response to allergen challenge. These different results confirm his efficacy and usefulness in allergic rhinitis.
Similar articles
-
Effect of allergen immunotherapy on soluble adhesion molecules.Allerg Immunol (Paris). 2001 Jun;33(6):225-8. Allerg Immunol (Paris). 2001. PMID: 11505805
-
Nasal ECP patterns and specific immunotherapy in mite-allergic rhinitis patients.Eur Ann Allergy Clin Immunol. 2005 Mar;37(3):96-102. Eur Ann Allergy Clin Immunol. 2005. PMID: 15918296 Clinical Trial.
-
Kinetics of eosinophil cationic protein release in mite-allergic rhinitis after specific nasal provocation.Allerg Immunol (Paris). 1998 Apr;30(4):104, 107-11. Allerg Immunol (Paris). 1998. PMID: 9631691
-
Nasal allergen challenge and mediators release.Allerg Immunol (Paris). 1997 Nov;29(9):269-71. Allerg Immunol (Paris). 1997. PMID: 9435923 Review.
-
[Rhinitis in adults].Acta Med Croatica. 2011;65(2):181-7. Acta Med Croatica. 2011. PMID: 22359885 Review. Croatian.
Cited by
-
[Specific immunotherapy in the treatment of atopic dermatitis].Hautarzt. 2007 Mar;58(3):232-6. doi: 10.1007/s00105-006-1220-x. Hautarzt. 2007. PMID: 17103200 Review. German.
-
[Atopic eczema. Spectrum of provocation factors and possibilities for their effective reduction and elimination].Hautarzt. 2003 Oct;54(10):914-24. doi: 10.1007/s00105-003-0557-7. Hautarzt. 2003. PMID: 14513237 Review. German.
-
[Specific immunotherapy (SIT) in atopic dermatitis and food allergy].Hautarzt. 2008 Jul;59(7):544-50. doi: 10.1007/s00105-008-1490-6. Hautarzt. 2008. PMID: 18528671 Review. German.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical